Engineered spider toxin could be the future of anti-venom vaccines
New engineered spider protein could be the start of a new generation of anti-venom vaccines, potentially saving thousands of lives worldwide. The new protein, created from parts of a toxin from the reaper ...
Medications
May 09, 2013 |
5 / 5 (3) |
0
|
Study compares effectiveness of 2 vs. 3 doses of HPV vaccine for girls and young women
With the number of doses and cost of human papillomavirus (HPV) vaccines a barrier to global implementation, researchers have found that girls who received two doses of HPV vaccine had immune responses to HPV-16 and HPV-18 ...
Cancer
Apr 30, 2013 |
not rated yet |
0
Study offers clues to making vaccine for infant respiratory illness
An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common—and sometimes very serious—childhood disease. ...
Diseases, Conditions, Syndromes
Apr 25, 2013 |
not rated yet |
0
|
Scientists find ethnicity linked to antibodies
(Medical Xpress)—Cracking the DNA code for a complex region of the human genome has helped 14 North American scientists, including five at Simon Fraser University, chart new territory in immunity research.
Genetics
Apr 17, 2013 |
5 / 5 (2) |
0
|
Discovery points to new approach to fight dengue virus
Researchers have discovered that rising temperature induces key changes in the dengue virus when it enters its human host, and the findings represent a new approach for designing vaccines against the aggressive ...
Diseases, Conditions, Syndromes
Apr 11, 2013 |
5 / 5 (1) |
0
|
Engineered antibody demonstrated safety, efficacy in wide range of advanced tumors
(Medical Xpress)—The engineered antibody MPDL3280A, which targets a protein called programmed death-ligand 1 (PD-L1), was safe and effective for several cancers, according to phase I study results presented at the AACR ...
Cancer
Apr 10, 2013 |
4 / 5 (1) |
0
Nothing fishy about it: Fish oil can boost the immune system
Fish oil rich in DHA and EPA is widely believed to help prevent disease by reducing inflammation, but until now, scientists were not entirely sure about its immune enhancing effects. A new report appearing in the April 2013 ...
Immunology
Apr 01, 2013 |
5 / 5 (1) |
0
New vaccine-design approach targets HIV and other fast-mutating viruses
A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly useful against ...
HIV & AIDS
Mar 28, 2013 |
4.8 / 5 (6) |
1
|
Study underlines potential of new technology to diagnose disease
Researchers at The Scripps Research Institute (TSRI) in Jupiter, FL, have developed cutting-edge technology that can successfully screen human blood for disease markers. This tool may hold the key to better diagnosing and ...
Medical research
Mar 21, 2013 |
5 / 5 (1) |
0
|
New monoclonal antibody developed that can target proteins inside cancer cells
Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer ...
Cancer
Mar 13, 2013 |
5 / 5 (6) |
0
|
Investigational drug reduces heart damage during angioplasty
A single dose of an investigational anti-inflammatory drug, inclacumab, reduced damage to heart tissue during angioplasty in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Cardiology
Mar 12, 2013 |
not rated yet |
1
Bridging the gap: Hope that all Meningitis strains will be vaccinated for
Scientists at the University of Southampton have taken a significant and important step in keeping people safe from the most common form of meningitis in the UK.
Diseases, Conditions, Syndromes
Feb 27, 2013 |
not rated yet |
0
First human tests of meth medication completed
(Medical Xpress)—InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight ...
Medications
Dec 20, 2012 |
not rated yet |
0
|
FDA approves new drug for inhaled anthrax
Federal health officials say they approved a new injectable drug from Human Genome Sciences to treat inhalable anthrax.
Medications
Dec 14, 2012 |
not rated yet |
0
Discovery could lead to faster diagnosis for some chronic fatigue syndrome cases
For the first time, researchers have landed on a potential diagnostic method to identify at least a subset of patients with chronic fatigue syndrome (CFS), a complex disorder with no known definitive cause or cure.
Diseases, Conditions, Syndromes
Nov 14, 2012 |
5 / 5 (1) |
0
|
